Tedizolid Phosphate
Acute bacterial skin and skin-structure infections (including MRSA)
- CAS No.
- 856867-55-5
- Indication Class
- Anti-infectives
- Patent Expiry
- To be assessed
- Therapeutic Area
- Anti-infective / Resistant Bacteria
- Labeled Purity
- 99%+
- Registration Readiness
- GMP/DMF
- Commercialization Tier
- API (Commercialized)
- Linked Intermediates
- Confirm per inquiry
Key Intermediates for This API
Order: listed intermediates that accept enquiries first; fragments shared across several APIs rank higherNo intermediate entries are on file for this API yet. You can still enquire by CAS number — we will route it to the supply side for manual sourcing.
Listing Logic · Why It's Worth Listing
A next-generation oxazolidinone with once-daily dosing and lower myelosuppression risk than peers, an important option against resistant Gram-positive bacteria.
Anti-infective / Resistant Bacteria · Marketed; available for immediate sourcing
GMP/DMF-ready; supports regulatory filing and audit in target markets
Intermediates confirmed per inquiry
Product Description
Tedizolid phosphate is a second-generation oxazolidinone antibiotic prodrug that treats infections caused by resistant Gram-positive bacteria by inhibiting bacterial protein synthesis.
Supply source: Unibest · Tedizolid Phosphate, sourced, vetted and delivered by Unibest. Therapeutic area, indication and listing rationale are qualitative summaries based on public drug knowledge for business reference; actual registration availability and quality specifications are subject to DMF/GMP documentation and the technical agreement confirmed at order.